ethinyl estradiol has been researched along with drospirenone in 221 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (0.90) | 18.2507 |
| 2000's | 107 (48.42) | 29.6817 |
| 2010's | 96 (43.44) | 24.3611 |
| 2020's | 16 (7.24) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Beier, S; Elger, W; Krattenmacher, R; Muhn, P; Schillinger, E | 1 |
| Dombrovicz, N; Foidart, JM; Heithecker, R; Oelkers, W; Welter, A | 1 |
| Parsey, KS; Pong, A | 1 |
| Freundl, F; Grillo, M; Heithecker, R; Helmerhorst, FM; Rosenbaum, P; Rossmanith, W; Schmidt, W; Thomas, K; Wolf, A; Wuttke, W | 1 |
| Foidart, JM; Gerlinger, C; Heithecker, R; Huber, J; Merki-Feld, GS; Schellschmidt, I; The, HS; Wuttke, W | 1 |
| Heithecker, R; Helmerhorst, FM; Oelkers, W; Wuttke, W | 1 |
| Smals, AG | 1 |
| Campana, A; Foidart, J; Heithecker, R; Helmerhorst, FM; Johannisson, E; Lüdicke, F | 1 |
| Blode, H; Foidart, JM; Heithecker, R | 1 |
| Brown, C; Ling, F; Wan, J | 1 |
| Oelkers, W | 1 |
| Gerlinger, C; Heithecker, R; van Haselen, CW; van Vloten, WA; van Zuuren, EJ | 1 |
| Yuzpe, AA | 1 |
| Thorneycroft, IH | 1 |
| Shulman, LP | 1 |
| Dickerson, V | 1 |
| Borenstein, J; Chiou, CF; Rapkin, A; Wade, S; Yu, HT | 1 |
| Buicu, C; Endrikat, J; Gaspard, U; Gerlinger, C; Heithecker, R; Lefebvre, P; Scheen, A | 1 |
| Armbruster, U; Bitzer, J; Meier-Burgoa, J; Schwendke, A; Tschudin, S | 1 |
| Heithecker, R; Mueck, AO; Schneidereit, R; Sillem, M | 1 |
| Beier, S; Elger, W; Garfield, R; Hillisch, A; Pollow, K; Shi, SQ | 1 |
| Suthipongse, W; Taneepanichskul, S | 1 |
| Aznar, J; Ferrando, F; García-Fuster, MJ; Mira, Y; Vayá, A | 1 |
| Buicu, C; Desager, JP; Endrikat, J; Gaspard, U; Gerlinger, C; Heithecker, R | 1 |
| Biggio, G; Concas, A; Fratta, S; Lello, S; Melis, GB; Orrù, M; Paoletti, AM; Ranuzzi, F; Sogliano, C | 1 |
| de Zegher, F; Ibáñez, L | 2 |
| Somma, MA | 1 |
| Apa, R; Giuliani, M; Guido, M; Lanzone, A; Romualdi, D; Selvaggi, L; Suriano, R | 1 |
| Bachmann, G; Benda, N; Marr, J; Sampson-Landers, C; Sulak, PJ | 1 |
| Cabré, S; De Zegher, F; Ibáñez, L; Valls, C | 1 |
| Gollnick, H; Schellschmidt, I; Thorneycroft, lH | 1 |
| Etzi, R; Floris, S; Fratta, S; Guerriero, S; Lello, S; Mallarini, G; Melis, GB; Orrù, M; Paoletti, AM; Ranuzzi, F; Sorge, R; Zedda, P | 1 |
| Di Spiezio Sardo, A; Giordano, E; Greco, E; Guida, M; Nappi, C; Tommaselli, GA | 1 |
| Bhathena, RK | 1 |
| Shirk, RA; Winneker, RC; Zhang, Z | 1 |
| Keam, SJ; Wagstaff, AJ | 1 |
| Klipping, C; Marr, J | 1 |
| Agnello, C; Caruso, S; Cianci, A; Di Mari, L; Farina, M; Intelisano, G; Sparacino, L | 1 |
| Brown, C; Foegh, M; Pearlstein, TB; Rapkin, A; Sampson-Landers, C; Yonkers, KA | 1 |
| Bachmann, GA; Pearlstein, TB; Yonkers, KA; Zacur, HA | 1 |
| Foidart, JM; Schellschmidt, I; Sulak, PJ; Zimmermann, D | 1 |
| Cabou, C; Caillaux, D; Damase-Michel, C; Elbaz, M; Fauvel, JM; Lacroix, I; Montastruc, JL; Roncalli, J | 1 |
| Endrikat, J; Gerlinger, C; Heithecker, R; Kluft, C; Mulder, SM | 1 |
| Cavenague, G; Machado, RB; Maia, E; Tachotti, F | 1 |
| Batukan, C; Muderris, II | 1 |
| Coffee, A; Kuehl, TJ; Sulak, PJ; Willis, S | 1 |
| Aubeny, E; Bastianelli, C; Birkhäuser, MH; Bjertnaes, A; Gruber, CJ; Knudsen, T; Lete, I; Lindh, I; Milsom, I; Rokstad, K | 1 |
| Coffee, AL; Kuehl, TJ; Sulak, PJ; Willis, S | 1 |
| Centeno, I; David, M; Gutierrez, E; Kahi, D; Pérez, M; Sánchez, LA | 1 |
| Aldrighi, JM; Andrade, RP; Borges, LE; Camargos, AF; Guazelli, C; Isaia, CF; Peixoto, FC; Petracco, A; Yazlle, ME | 1 |
| Ahrendt, HJ; Bastianelli, C; Bitzer, J; Gemzell-Danielsson, K; Gómez, MA; Karskov, B; Milsom, I; Nisand, I; Oeyen, L; Page, G; Urdl, W | 1 |
| Alincic, S; Cibula, D; Karck, U; Kunz, J; Marr, J; Weidenhammer, HG | 1 |
| Loughlin, J; Mona Eng, P; Oh, K; Seeger, JD; Walker, AM | 1 |
| Fratta, S; Fruzzetti, F; Genazzani, AR; Lazzarini, V; Lello, S; Melis, GB; Minerba, L; Orrù, M; Paoletti, AM; Ricci, C; Sorge, R | 1 |
| Cianci, A; De Leo, V; Morgante, G; Musacchio, MC; Petraglia, F; Piomboni, P | 1 |
| Jaisamrarn, U; Phupong, V; Taneepanichskul, S | 1 |
| Mitkov, M; Pehlivanov, B | 1 |
| Rapkin, AJ; Winer, SA | 1 |
| Batukan, C; Muderris, II; Ozcelik, B; Ozturk, A | 1 |
| Coffee, AL; Kuehl, TJ; Sulak, PJ | 2 |
| Fenton, C; Moen, MD; Robinson, DM; Wellington, K | 1 |
| Fruzzetti, F; Gambacciani, M; Genazzani, AR; Lazzarini, V; Paoletti, AM; Quirici, B; Ricci, C | 1 |
| Oranratanaphan, S; Taneepanichskul, S | 1 |
| Endrikat, J; Fortier, M; Gerlinger, C; Rübig, A; Sandri, M; Schmidt, W | 1 |
| Clifford, CR; Cutone, J; Eng, PM; Loughlin, J; Seeger, JD; Walker, AM | 1 |
| Elkin, A; Jawetz, RE; Jawetz, SA; Michael, L; Shin, HT | 1 |
| Dal Pan, GJ; McAdams, M; Staffa, JA | 1 |
| Amarasinghe, AA; Don, CK; Marasinghe, JP | 1 |
| Cianci, A; De Leo, V | 1 |
| Tan, JK | 1 |
| Ciurea, A; Krunic, A; Scheman, A | 1 |
| Corrocher, R; Olivieri, O; Pavan, C; Pizzolo, F | 1 |
| Cohen, LS; Gottshcall, H; Hall, JE; Joffe, H; Petrillo, LF; Soares, CN; Viguera, AC | 1 |
| Benda, N; Blode, H; Schürmann, R | 1 |
| Drosdzol, A; Skrzypulec, V | 1 |
| Rich, P | 1 |
| Koltun, W; Korner, P; Lucky, AW; Marr, J; Niknian, M; Sampson-Landers, C; Thiboutot, D | 2 |
| Bakalianou, K; Creatsas, G; Gregoriou, O; Konidaris, S; Papadias, K; Salakos, N; Vrachnis, N | 1 |
| Rapkin, AJ; Sorger, SN; Winer, SA | 1 |
| Agnello, C; Caruso, S; Cianci, A; Di Mari, L; Grillo, C; Serra, A | 1 |
| Pérez-López, FR | 1 |
| Coffee, A; Kuehl, TJ; Speikermann, AM; Sulak, PJ; Willis, SA | 1 |
| Ozdemir, M; Ozdemir, S; Toy, H | 1 |
| Bilchugova, E; Colonna, L; Guardianelli, F; Lello, S; Pallotta, P; Primavera, G; Raskovic, D; Sorge, R; Vittori, G | 1 |
| Di Carlo, C; Formisano, C; Gargano, V; Massaro, M; Morra, I; Nappi, C | 1 |
| Duijkers, I; Klipping, C; Marr, J; Trummer, D | 1 |
| Gezginç, K; Görkemli, H; Kiyici, A; Ozdemir, M; Ozdemir, S | 1 |
| Frauens, BJ; Garmizo, G | 1 |
| Dietze, P; Korner, P; Lee-Rugh, S; Maloney, JM; Niknian, M; Sampson-Landers, C; Watson, D | 2 |
| Clifford, CR; Cutone, J; Eng, PM; Foegh, M; Loughlin, J; Seeger, JD; Walker, AM | 1 |
| Mishell, DR | 2 |
| Rapkin, AJ | 1 |
| Kimball, AB | 1 |
| Adali, E; Birol, F; Suer, N; Yildizhan, B; Yildizhan, R; Yoruk, P | 1 |
| Colonna, L; Guardianelli, F; Lello, S; Primavera, G; Raskovic, D; Sorge, R; Vittori, G | 1 |
| Tanne, JH | 1 |
| Short, M | 1 |
| De Leo, V; Hernádi, L; Marr, J; Petraglia, F; Trummer, D | 1 |
| Cabral, CA; Cardoso, LE; Sampaio, FJ; Zamboni, MJ | 1 |
| Balteau, B; Claesen, J; De Groote, D; Foidart, JM; Gerday, C; Perrier d'Hauterive, S; Pintiaux, A | 1 |
| Assmann, A; Bardenheuer, K; Dinger, JC | 1 |
| Fruzzetti, F; Gambacciani, M; Genazzani, AR; Lazzarini, V; Parrini, D; Perini, D | 1 |
| Burkman, RT; Fisher, AC; Kaunitz, AM; LaGuardia, KD | 1 |
| Athayde, C; Casoy, J; Coutinho, EM; Maia, H; Valente Filho, J | 1 |
| Cruz, AM; de Melo, NR; Machado, RB; Maia, H | 1 |
| de Melo, NR; Machado, RB; Maia, H | 1 |
| Bunya, VY; Makar, GA; Orlin, A; Orlin, SE | 1 |
| Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
| Chaiyasit, N; Taneepanichskul, S | 1 |
| Assmann, A; Dinger, J; Minh, TD; Möhner, S | 1 |
| Duijkers, IJ; Grob, P; Klipping, C; Korver, T | 1 |
| Cianci, A; De Leo, V; Di Sabatino, A; Morgante, G; Musacchio, MC; Petraglia, F; Scolaro, V | 1 |
| Amodai, I; Ber, A; Feinstein, I; Finkel, I; Gordon, N; Porat, N; Samuel, D; Seidman, DS; Shiran-Makler, E; Wolman, I; Yeshaya, A | 1 |
| Colonna, L; Guardianelli, F; Lello, S; Melis, GB; Pacifico, V; Paoletti, AM; Primavera, G; Raskovic, D; Sorge, R | 1 |
| Giribela, AG; Giribela, CG; Machado, RB; Pompei, Lde M | 1 |
| Reid, R | 1 |
| Gul, S; Kelekci, KH; Kelekci, S; Yengel, I; Yilmaz, B | 1 |
| Anttila, L; Bachmann, G; Hernádi, L; Klipping, C; Kunz, M; Marr, J | 1 |
| Koltun, W; Kunz, M; Maloney, JM; Marr, J | 1 |
| Agnello, C; Caruso, S; Cianci, A; Iraci Sareri, M; Lo Presti, L; Malandrino, C; Romano, M | 1 |
| Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW | 1 |
| Heinemann, K; Kunz, M; Marr, J; Rapkin, A | 1 |
| Biringer, K; Biringerová, Z; Svecová, I; Visnovský, J | 1 |
| Ahmed, AH; Gordon, RD; Pimenta, E; Stowasser, M; Taylor, PJ; Ward, G | 1 |
| Newens, KJ; Przemska, A; Thompson, AK; Vasilopoulou, D; Williams, CM | 1 |
| Bressler, B; Brophy, JM; Delaney, JA; Etminan, M | 1 |
| Karabay, CY; Kocabay, G; Zehir, R | 1 |
| El-Sherbiny, WS; Mohamed, AM; Mostafa, WA | 1 |
| Ribowsky, JH | 1 |
| Creinin, MD; Rapkin, RB | 1 |
| Abild-Nielsen, A; Bjarnason, NH; Mogensen, SS | 1 |
| Korver, T; Mansour, D; Melis, GB; Sommer, W; Sundström-Poromaa, I; Taneepanichskul, S; Verhoeven, C; Weisberg, E | 1 |
| Muderris, II; Oner, G | 1 |
| Bart, S; Diefenbach, K; Marr, J; Sampson-Landers, C; Trummer, D | 1 |
| Voelker, R | 1 |
| Del Forno, S; Ferrini, G; Frascà, C; Mabrouk, M; Montanari, G; Paradisi, R; Seracchioli, R; Solfrini, S | 1 |
| Freitas, A; Howard, DM; Lã, FM; Sa-Couto, P; Sundberg, J | 1 |
| Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Liu, X; Pepe, SR | 1 |
| Helmerhorst, FM; Kaptein, AA; Lopez, LM | 1 |
| Anzai, Y; Heger-Mahn, D; Marr, J; Schellschmidt, I | 1 |
| Baracat, EC; Consolim-Colombo, FM; Giribela, CR; Guerra, GM; Hong, VM; Melo, NR; Silva, RC | 1 |
| Bayraktar, M; Cinar, N; Harmanci, A; Yildiz, BO | 1 |
| Bahamondes, L; Darney, P; Kaunitz, AM; Korver, T; Sommer, W; Verhoeven, C; Westhoff, C | 1 |
| Haydardedeoglu, B; Kilicdag, EB; Parlakgumus, AH; Zeyneloglu, HB | 1 |
| Blode, H; Kowal, K; Reif, S; Roth, K | 1 |
| Horváth, D; Kovács, GL; Lőcsei, Z; Rácz, K; Szabolcs, I; Toldy, E | 1 |
| Aksoy, DY; Aydin, K; Bozdag, G; Cinar, N; Yildiz, BO | 1 |
| Blode, H; Diefenbach, K; Eydeler, U; Richard, F; Rohde, B; Trummer, D; Wiesinger, H | 1 |
| General, S; Nippe, S | 1 |
| Velev, P | 1 |
| Mansour, D; Shapiro, S; Szarewski, A | 1 |
| Arangino, S; Cagnacci, A; Ferrari, S; Napolitano, A; Piacenti, I; Volpe, A | 1 |
| Blode, H; Reif, S; Snelder, N | 1 |
| Bird, ST; Brophy, JM; Delaney, JA; Etminan, M; Hartzema, AG | 1 |
| Coelingh Bennink, HJ; Ebes, F; Fauser, BC; Wouters, W; Zimmerman, Y | 1 |
| Ambrosio, D; Cerreto, FV; De Franciscis, P; Labriola, D; Leo, S; Luisi, A; Mainini, G; Russo, C; Santangelo, F; Torella, M | 1 |
| Aksoy, DY; Arusoglu, G; Cinar, N; Koksal, G; Tapan, S; Yildiz, BO | 1 |
| Busacca, M; De Cicco, S; Gagliano, D; Guido, M; Lanzone, A; Romualdi, D | 1 |
| Caruso, S; Cianci, A; Cianci, S; Cicero, C; Lo Presti, L; Malandrino, C | 1 |
| Baracat, EC; Consolim-Colombo, FM; de Angelis, K; de Melo, NR; de Morais, TL; Giribela, CR; Guerra, GM; Mostarda, C; Nisenbaum, MG | 1 |
| de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A | 1 |
| Atabekoğlu, CS; Ateş, C; Berker, B; Cetinkaya, SE; Kahraman, K; Ozmen, B; Sönmezer, M; Sükür, YE; Taşkın, S; Tolunay, HE | 1 |
| Cagnacci, A; Piacenti, I; Tirelli, A; Xholli, A; Zanin, R | 1 |
| Bannemerschult, R; Endrikat, J; Gerlinger, C; Marr, J; Mellinger, U; Merz, M; Schellschmidt, I; Trussell, J | 1 |
| Bakas, P; Creatsas, G; Grigoriadis, C; Hassiakos, D; Liapis, A; Vlahos, NF | 1 |
| Baihua, D; Caiyan, W; Hongyu, W; Huan, S; Liangdan, T; Meiqing, X; Mulan, R; Qinping, L; Shulan, Z; Wen, D; Xiaomao, L; Xiaoyan, X; Youdi, X; Yufeng, L; Zheng'ai, X; Zhisong, M; Zirong, H; Ziyan, H | 1 |
| Baracat, E; Consolim-Colombo, FM; de Morais, TL; Giribela, C; Guerra, G; Mello, N; Nisenbaum, MG | 1 |
| Cheng, W; Fu, Y; Li, L; Mi, W; Sun, L; Wang, J; Xie, S; Zhang, H; Zhang, J | 1 |
| El-Haggar, SM; Mostafa, TM | 1 |
| Cim, N; Gokce, AI; Yildizhan, B; Yildizhan, R | 1 |
| Arata, K; Enatsu, A; Harada, T; Ota, I; Taniguchi, F; Toda, T | 1 |
| Baracat, EC; Consolim-Colombo, FM; Giribela, AH; Giribela, CR; Melo, NR; Moraes, TL; Nisenbaum, MG | 1 |
| Coelingh Bennink, HJ; Foidart, JM; Klipping, C; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
| Berse, M; Gschwend, S; Höchel, J; Klein, S; Schütt, B; Wiesinger, H; Zollmann, FS | 1 |
| Hayakawa, J; Hayakawa, K; Hiramatsu, K; Koga, S; Kondo, A; Takeda, T; Yaegashi, N | 1 |
| Al-Jefout, M; Nawaiseh, N | 1 |
| Appels, N; Coelingh Bennink, HJ; Duijkers, IJ; Foidart, JM; Jost, M; Klipping, C; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
| Alessandri, F; Bogliolo, S; Ferrero, S; Gardella, B; Grillo, F; Leone Roberti Maggiore, U; Mastracci, L; Tafi, E; Vellone, VG | 1 |
| Bhattacharya, SM; DasMukhopadhyay, L; Jha, A | 1 |
| Dinger, J; Heinemann, K; Möhner, S | 1 |
| Chew, G; Fent, K; Riva, F; Rossier, NM; Zhang, K | 1 |
| Bottiglieri, P; Colao, A; Colarieti, G; Giallauria, F; Muscogiuri, G; Orio, F; Palomba, S; Predotti, P; Savastano, S; Tafuri, D | 1 |
| Czilli, T; Knezevic, S; Peters, C; Tan, J | 1 |
| Camões, S; Lopes, C; Rocha, J; Sampaio, J; Tiago, P | 1 |
| Bennink, HC; Duijkers, IJM; Foidart, JM; Klipping, C; Kluft, C; Mawet, M; Neuteboom, J; Zimmerman, Y | 1 |
| Gao, G; Li, L; Nai, M; Wang, L | 1 |
| Fujii, T; Harada, M; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Makabe, T; Miyashita, M; Osuga, Y; Sue, F; Taguchi, A; Takamura, M; Takeuchi, A; Urata, Y; Wada-Hiraike, O | 1 |
| Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y | 1 |
| Hussein, AM; Kamal, WM; Kamel, AM; Maged, AM; Meshaal, H; Saad, H; Salah, E | 1 |
| Canu, E; Fulghesu, AM; Melis, F; Melis, GB; Murru, G | 1 |
| Acmaz, G; Atas, M; Madendag, IÇ; Madendag, Y; Özdemir, F; Sahin, E; Senol, V; Tayyar, AT | 1 |
| Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L | 1 |
| Li, L; Yan, L | 1 |
| Atalay, CR; Özdemir, Ö; Yahşi, GG | 1 |
| Adeyanju, OA; Olatunji, LA | 1 |
| Chang, W; Dragoo, JL; Hsue, L; Konopka, JA; Thio, T | 1 |
| Das, M; Kearney, BP; Ling, KH; Majeed, SR; West, S | 1 |
| Bester, J; de Lange-Loots, Z; Swanepoel, AC | 1 |
| Douxfils, J; Duijkers, I; Foidart, JM; Jost, M; Kinet, V; Klipping, C; Maillard, C; Mawet, M; Rosing, J | 1 |
| Dumka, VK; Lonare, MK; Mir, AH; Sultan, F | 1 |
| Bastidas, A; Duijkers, I; Foidart, JM; Jost, M; Klipping, C; Maillard, C; Mawet, M | 1 |
| Bastidas, A; Duijkers, I; Foidart, JM; Jost, M; Kinet, V; Klipping, C | 1 |
| Achilles, SL; Archer, DF; Bouchard, C; Chen, MJ; Creinin, MD; Foidart, JM; Jensen, JT; Kaunitz, AM; Westhoff, CL | 1 |
| Bester, J; Davoren, E; du Preez, I; Kruger, Y; Swanepoel, A | 1 |
| Erasmus, E; van der Berg, CL; van der Westhuizen, FH; Venter, G | 1 |
| Dogné, JM; Douxfils, J; Foidart, JM; Gaspard, U; Jost, M; Morimont, L | 1 |
| Achilles, SL; Apolikhina, I; Archer, DF; Bouchard, C; Chen, MJ; Creinin, M; Foidart, JM; Jensen, JT; Jost, M; Kaunitz, AM; Piltonen, T; Suturina, L; Weyers, S; Zatik, J | 1 |
| Colli, E; Regidor, PA | 1 |
| Del Savio, MC; Facchinetti, F; Grandi, G; Melotti, C | 1 |
| González-Mariño, I; Pavón, JLP; Peña, J | 1 |
| Ahmad, W; Farooq, U; Mahmood Arshad, RK; Mehmood, Y; Riaz, H; Shahid, H; Yousaf, H | 1 |
| Capasso, F; De Franciscis, P; Facchinetti, F; Ferrara, C; Grandi, G; Guida, M; Iaccheri, M; Marietta, M; Quercitelli, L | 1 |
18 review(s) available for ethinyl estradiol and drospirenone
| Article | Year |
|---|---|
The renin-aldosterone system and drospirenone.
Topics: Androstenes; Animals; Blood Pressure; Body Weight; Ethinyl Estradiol; Humans; Natriuresis; Progesterone; Receptors, Steroid; Renin-Angiotensin System; Transcriptional Activation | 2002 |
Oral contraception: trends over time.
Topics: Adult; Androstenes; Breast Neoplasms; Contraception; Contraceptives, Oral, Combined; Contraindications; Ethinyl Estradiol; Female; Humans; Middle Aged; Patient Compliance; Pregnancy; Progestins; Risk Factors; Thrombosis | 2002 |
Evolution of progestins. Focus on the novel progestin drospirenone.
Topics: Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Mineralocorticoids; Progesterone Congeners | 2002 |
Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
Topics: Acne Vulgaris; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Mineralocorticoids; Premenstrual Syndrome; Progesterone Congeners; Quality of Life; Randomized Controlled Trials as Topic; Weight Gain | 2002 |
Ethinylestradiol/drospirenone: a review of its use as an oral contraceptive.
Topics: Absorption; Androstenes; Contraception; Contraceptives, Oral; Drug Interactions; Ethinyl Estradiol; Female; Humans; Kidney Diseases; Lactation; MEDLINE; Progesterone Congeners; Tissue Distribution | 2003 |
Drospirenone: a novel progestin.
Topics: Acne Vulgaris; Androgen Antagonists; Androstenes; Animals; Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Combinations; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Progesterone Congeners | 2007 |
Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome | 2007 |
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Topics: Androstenes; Contraception; Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Evidence-Based Medicine; Female; Humans; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Patient Satisfaction; Practice Guidelines as Topic; Pregnancy; Premenstrual Syndrome; Progesterone; Quality of Life | 2007 |
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
Hormonal contraceptives for acne management.
Topics: Acne Vulgaris; Androstenes; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Skin | 2008 |
Drospirenone/ethinyl estradiol.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome | 2008 |
Clinical experiences with drospirenone: from reproductive to postmenopausal years.
Topics: Androstenes; Contraceptives, Oral, Combined; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Menopause; Mineralocorticoid Receptor Antagonists | 2008 |
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Drospirenone/ethinylestradiol: a review on efficacy and noncontraceptive benefits.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Combined; Dysmenorrhea; Endometrium; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome | 2011 |
The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium.
Topics: Androstenes; Calcium; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glutamates; Humans; Neural Tube Defects | 2011 |
Oral contraceptives containing drospirenone for premenstrual syndrome.
Topics: Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Premenstrual Syndrome; Randomized Controlled Trials as Topic | 2012 |
Combined oral contraceptives: venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis | 2014 |
Advances in pharmacotherapy for treating endometriosis.
Topics: Androstenes; Anti-Inflammatory Agents, Non-Steroidal; Aromatase Inhibitors; Contraceptives, Oral, Combined; Endometriosis; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Progestins | 2015 |
108 trial(s) available for ethinyl estradiol and drospirenone
| Article | Year |
|---|---|
Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Topics: Adolescent; Adult; Aldosterone; Androstenes; Angiotensin I; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Lipids; Mineralocorticoids; Renin; Renin-Angiotensin System | 1995 |
Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol.
Topics: Adult; Androstenes; Contraceptives, Oral; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovulation; Progesterone; Progesterone Congeners | 2000 |
Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Skin; Weight Gain | 2000 |
Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.
Topics: Adolescent; Adult; Aldosterone; Androstenes; Angiotensinogen; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System | 2000 |
Transfer of drospirenone to breast milk after a single oral administration of 3 mg drospirenone + 30 microg ethinylestradiol to healthy lactating women.
Topics: Adult; Androstenes; Area Under Curve; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Infant, Newborn; Lactation; Milk, Human; No-Observed-Adverse-Effect Level; Progesterone Congeners; Radioimmunoassay | 2001 |
A new monophasic oral contraceptive containing drospirenone. Effect on premenstrual symptoms.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Patient Satisfaction; Premenstrual Syndrome; Probability; Treatment Outcome | 2002 |
The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Cyproterone; Dermatitis, Seborrheic; Double-Blind Method; Drug Administration Schedule; Drug Evaluation, Preclinical; Ethinyl Estradiol; Facial Dermatoses; Female; Germany; Humans; Netherlands; Progesterone Congeners; Severity of Illness Index; Treatment Outcome | 2002 |
A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism.
Topics: Adolescent; Adult; Androstenes; Blood Glucose; Blood Pressure; Body Weight; C-Peptide; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fasting; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Humans; Insulin; Kinetics | 2003 |
[Effects on the quality of life of a new oral contraceptive containing 30 mcg EE and 3 mg drospirenone (Yasmin)].
Topics: Adult; Androstenes; Body Weight; Contraceptives, Oral; Data Interpretation, Statistical; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Libido; Menstruation; Progesterone Congeners; Quality of Life; Surveys and Questionnaires; Time Factors | 2003 |
An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women.
Topics: Adolescent; Adult; Androstenes; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Thailand | 2004 |
A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
Topics: Adolescent; Adult; Androstenes; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Prospective Studies; Triglycerides | 2004 |
Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol.
Topics: Adult; Androstenes; Anxiety; Contraceptives, Oral, Combined; Desoxycorticosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Follicular Phase; Humans; Luteal Phase; Phobic Disorders; Pregnanolone; Progesterone; Psychometrics | 2004 |
Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Topics: Adiponectin; Adipose Tissue; Adolescent; Adult; Androgen Antagonists; Androstenes; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Flutamide; Hormone Antagonists; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Interleukin-6; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Proteins | 2004 |
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.
Topics: Adult; Androstenes; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Pilot Projects; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides | 2004 |
Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Headache; Humans; Patient Compliance; Patient Satisfaction; Pregnancy; Progesterone Congeners; Uterine Hemorrhage | 2004 |
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
Topics: Adiponectin; Adolescent; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Interleukin-6; Lipolysis; Metformin; Polycystic Ovary Syndrome; Proteins | 2004 |
Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Norgestrel; Prospective Studies; Treatment Outcome | 2004 |
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
Topics: Adolescent; Adult; Androstenes; Arteriosclerosis; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Lipolysis; Metformin; Polycystic Ovary Syndrome; Time Factors | 2005 |
Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
Topics: Adult; Amino Acids; Androstenes; Bone Density; Bone Remodeling; Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Norpregnenes; Osteocalcin; Progesterone Congeners | 2005 |
Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism.
Topics: Adult; Androstenes; Carbohydrate Metabolism; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Hemostasis; Humans; Lipid Metabolism | 2005 |
Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome; Progesterone Congeners; Quality of Life; Treatment Outcome; Uterine Hemorrhage | 2005 |
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.
Topics: Adult; Androstenes; Contraceptives, Oral; Cross-Over Studies; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Placebos; Premenstrual Syndrome | 2005 |
The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days.
Topics: Adult; Androstenes; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Patient Satisfaction; Prospective Studies; Time Factors; Uterine Hemorrhage | 2006 |
A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.
Topics: Adolescent; Adult; Androstenes; Antithrombins; Coagulants; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Homeostasis; Humans; Prospective Studies; Protein C; Protein S | 2006 |
Effects of two different oral contraceptives on total body water: a randomized study.
Topics: Adult; Androstenes; Body Composition; Body Water; Contraceptives, Oral; Electric Impedance; Ethinyl Estradiol; Female; Humans; Norpregnenes; Prospective Studies | 2006 |
Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
Topics: Adult; Androstenedione; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome | 2006 |
Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Menstruation; Middle Aged; Prospective Studies | 2006 |
Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
Topics: Administration, Oral; Adult; Androstenes; Body Composition; Body Weight; Contraceptive Devices, Female; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Humans; Intrauterine Devices; Menstrual Cycle; Patient Compliance | 2006 |
Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen.
Topics: Adult; Affect; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2006 |
Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.
Topics: Adolescent; Adult; Affect; Androstenes; Blood Pressure; Body Fluids; Body Weight; Contraception; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Premenstrual Syndrome; Progesterone Congeners | 2006 |
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
Topics: Adolescent; Adult; Androstenes; Contraception; Contraceptive Agents; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Patient Compliance; Patient Satisfaction; Pregnancy; Progesterone Congeners; Treatment Outcome | 2006 |
Efficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20microg and drospirenone 3mg.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Patient Compliance; Patient Satisfaction | 2006 |
The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: an observational study.
Topics: Adolescent; Adult; Androstenes; Body Composition; Body Water; Body Weight; Contraceptives, Oral, Combined; Electric Impedance; Estrogens; Ethinyl Estradiol; Extracellular Fluid; Female; Humans; Intracellular Fluid; Luteal Phase; Mineralocorticoid Receptor Antagonists; Mineralocorticoids | 2007 |
Effect of a new oral contraceptive with drospirenone on vital signs, complete blood count, glucose, electrolytes, renal, and liver function.
Topics: Adult; Androstenes; Blood Cell Count; Blood Glucose; Blood Pressure; Contraceptives, Oral; Ethinyl Estradiol; Female; Heart Rate; Humans; Kidney; Liver; Water-Electrolyte Balance | 2007 |
Efficacy of an oral contraceptive containing drospirenone in the treatment of women with polycystic ovary syndrome.
Topics: Adult; Androstenes; Blood Glucose; Body Mass Index; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Polycystic Ovary Syndrome; Prospective Studies; Severity of Illness Index; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2007 |
Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Prospective Studies; Treatment Outcome | 2007 |
Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.
Topics: Affect; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Headache; Humans; Menstruation; Patient Satisfaction; Pelvic Pain; Prospective Studies; Texas; Treatment Outcome | 2007 |
Effect of an oral contraceptive containing 30 microg ethinylestradiol plus 3 mg drospirenone on body composition of young women affected by premenstrual syndrome with symptoms of water retention.
Topics: Adult; Androstenes; Body Fluid Compartments; Case-Control Studies; Estrogens; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Prospective Studies | 2007 |
A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido.
Topics: Adult; Androgens; Androstenes; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Health Surveys; Humans; Norpregnenes; Patient Satisfaction; Progesterone Congeners; Sexual Behavior; Surveys and Questionnaires; Thailand; Time Factors | 2006 |
A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight.
Topics: Adult; Androstenes; Body Water; Body Weight; Canada; Contraceptives, Oral, Combined; Edema; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Prospective Studies; Severity of Illness Index; Surveys and Questionnaires | 2007 |
Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary report.
Topics: Adult; Androstenes; Antidepressive Agents; Contraceptives, Oral; Depressive Disorder; Drug Therapy, Combination; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Progesterone; Severity of Illness Index; Treatment Outcome | 2007 |
Novel ethinyl estradiol-beta-cyclodextrin clathrate formulation does not influence the relative bioavailability of ethinyl estradiol or coadministered drospirenone.
Topics: Aged; Androstenes; beta-Cyclodextrins; Biological Availability; Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cross-Over Studies; Ethinyl Estradiol; Female; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Preservatives, Pharmaceutical; Suspensions; Tablets | 2008 |
Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Ethinyl Estradiol; Humans; Middle Aged; Treatment Outcome | 2008 |
Treatment of hirsutism with combined pill containing drospirenone.
Topics: Administration, Oral; Adolescent; Adult; Androstenes; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Greece; Hirsutism; Humans; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 2008 |
Prospective study on the cytological aspects of the nasal respiratory epithelium in premenopausal women taking 30 mcg ethinylestradiol and 3 mg drospirenone oral contraceptive.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Nasal Mucosa; Premenopause; Prospective Studies | 2008 |
Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives.
Topics: Adolescent; Adult; Affect; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Surveys and Questionnaires; Weights and Measures | 2008 |
Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Topics: Adult; Amino Acids; Androstenes; Bone and Bones; Bone Density; Bone Remodeling; Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Osteocalcin | 2008 |
Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.
Topics: Adolescent; Adult; Androstenes; Confidence Intervals; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Humans; Odds Ratio; Ovary; Treatment Outcome | 2008 |
Clinical and metabolic effects of medroxyprogesterone acetate and ethinyl estradiol plus drospirenone in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgens; Androstenes; Carbohydrate Metabolism; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Lipid Metabolism; Luteinizing Hormone; Medroxyprogesterone Acetate; Menstrual Cycle; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2008 |
A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Middle Aged; Treatment Outcome | 2008 |
Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Middle Aged; Treatment Outcome | 2008 |
Effects of two combined oral contraceptives containing ethinyl estradiol 30 microg combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure.
Topics: Adult; Androstenes; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norpregnenes; Young Adult | 2009 |
Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Androstenedione; Androstenes; Chlormadinone Acetate; Dehydroepiandrosterone Sulfate; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hair; Humans; Hyperandrogenism; Luteinizing Hormone; Sex Hormone-Binding Globulin; Skin Diseases; Testosterone; Young Adult | 2008 |
Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen.
Topics: Adult; Androstenes; Delayed-Action Preparations; Estrogens; Ethinyl Estradiol; Europe; Female; Humans; Medication Adherence; Patient Satisfaction; Progesterone Congeners; Women's Health; Young Adult | 2009 |
Oral hormonal contraceptives affect the concentration and composition of urinary glycosaminoglycans in young women.
Topics: Adult; Androstenes; Chondroitin Sulfates; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Dermatan Sulfate; Ethinyl Estradiol; Female; Glycosaminoglycans; Heparitin Sulfate; Humans; Norpregnenes | 2009 |
A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Middle Aged; Treatment Outcome; Young Adult | 2009 |
Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Topics: Administration, Oral; Adolescent; Adult; Androgens; Androstenes; Blood Pressure; Cardiovascular Diseases; Cyproterone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2010 |
Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Metrorrhagia; Mineralocorticoid Receptor Antagonists; Norgestrel; Young Adult | 2009 |
Effect of a continuous regimen of contraceptive combination of ethinylestradiol and drospirenone on lipid, carbohydrate and coagulation profiles.
Topics: Adolescent; Adult; Analysis of Variance; Androstenes; Blood Coagulation; Blood Coagulation Tests; Blood Glucose; Contraceptives, Oral; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Intention to Treat Analysis; Lipids; Patient Selection; Prospective Studies; Statistics, Nonparametric | 2010 |
Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study.
Topics: Adult; Amenorrhea; Analysis of Variance; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Intention to Treat Analysis; Longitudinal Studies; Metrorrhagia; Patient Satisfaction; Prospective Studies; Quality of Life; Statistics, Nonparametric; Treatment Outcome; Women's Health | 2010 |
A study of cycle control, side effects and client's satisfaction of a low dose combined contraceptive containing ethinylestradiol/drospirenone (24/4 regimen).
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Patient Compliance; Patient Satisfaction; Treatment Outcome; Young Adult | 2010 |
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estradiol; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Megestrol; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Norpregnadienes; Ovulation; Progesterone; Young Adult | 2010 |
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Norpregnenes; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Young Adult | 2010 |
Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens.
Topics: Adolescent; Adult; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Severity of Illness Index; Spironolactone; Time Factors; Treatment Outcome; Young Adult | 2012 |
Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Medication Adherence; Pregnancy; Pregnancy Rate; Progestins; Statistics as Topic; Young Adult | 2011 |
Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Humans; Progestins; Severity of Illness Index; Young Adult | 2011 |
Conventional vs. extended-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 µg ethinyl estradiol.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Delayed-Action Preparations; Ethinyl Estradiol; Female; Humans; Personal Satisfaction; Psychological Tests; Quality of Life; Sexual Behavior; Surveys and Questionnaires; Young Adult | 2011 |
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones | 2011 |
Ethinyl estradiol 20μg/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome; Psychometrics; Severity of Illness Index; Treatment Outcome | 2011 |
[Hormonal treatment effectivity in hyperandrogenic syndrome].
Topics: Adult; Androgen Antagonists; Androstenes; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Syndrome | 2010 |
Combined oral contraceptive pills containing desogestrel or drospirenone enhance large vessel and microvasculature vasodilation in healthy premenopausal women.
Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Gene Expression Regulation, Enzymologic; Humans; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Nitric Oxide Synthase Type III; Time Factors; Vasodilation | 2011 |
Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone).
Topics: Acne Vulgaris; Adolescent; Adult; Affective Symptoms; Androstenes; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Leukorrhea; Libido; Lipoproteins, LDL; Metrorrhagia; Vaginitis; Weight Gain; Young Adult | 2011 |
Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Megestrol; Menstrual Cycle; Metrorrhagia; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnadienes; Pregnancy; Pregnancy Rate; Substance Withdrawal Syndrome; Young Adult | 2011 |
A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Hirsutism; Humans; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2011 |
Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study.
Topics: Adolescent; Adult; Androstenes; Calcium; Contraceptives, Oral; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Folic Acid; Glutamates; Homocysteine; Humans; Mineralocorticoid Receptor Antagonists; Neural Tube Defects; Treatment Outcome; Young Adult | 2012 |
Effects of the menstrual cycle and oral contraception on singers' pitch control.
Topics: Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Phonation; Speech Production Measurement; Statistics, Nonparametric; Voice | 2012 |
Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women.
Topics: Adolescent; Adult; Androstenes; Asian People; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Mineralocorticoid Receptor Antagonists; Ovary; Ovulation; Patient Compliance; Pregnancy; White People; Young Adult | 2012 |
A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Hemodynamics; Humans; Mineralocorticoid Receptor Antagonists; Prospective Studies | 2012 |
Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Humans; Kaplan-Meier Estimate; Megestrol; Middle Aged; Norpregnadienes; Pregnancy; Proportional Hazards Models; Young Adult | 2012 |
IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial.
Topics: Adult; Androstenes; Clinical Protocols; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Sperm Injections, Intracytoplasmic; Young Adult | 2012 |
Bioequivalence evaluation of a folate-supplemented oral contraceptive containing ethinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone and levomefolate calcium alone.
Topics: Adolescent; Adult; Algorithms; Androstenes; Area Under Curve; Calcium; Contraceptives, Oral, Hormonal; Cross-Over Studies; Double-Blind Method; Ethinyl Estradiol; Female; Folic Acid; Glutamates; Half-Life; Humans; Mineralocorticoid Receptor Antagonists; Nutritional Status; Tetrahydrofolates; Vitamins; Young Adult | 2012 |
Characterisation of the pharmacokinetics of ethinylestradiol and drospirenone in extended-cycle regimens: population pharmacokinetic analysis from a randomised Phase III study.
Topics: Adult; Androstenes; Delayed-Action Preparations; Ethinyl Estradiol; Female; Humans; Reproductive Control Agents; Young Adult | 2013 |
The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
Topics: Adult; Analysis of Variance; Androstenes; Contraceptives, Oral, Combined; Cross-Over Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Prospective Studies; Testosterone | 2013 |
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.
Topics: Adolescent; Adult; Androstenes; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Combinations; Ethinyl Estradiol; Female; Glucose Clamp Technique; Hirsutism; Humans; Hyperandrogenism; Pilot Projects; Polycystic Ovary Syndrome; Triglycerides | 2013 |
Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial.
Topics: Adult; Androstenes; Autonomic Nervous System; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Hemodynamics; Humans; Mineralocorticoid Receptor Antagonists; Prospective Studies | 2014 |
Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenes; Biomarkers; Body Mass Index; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Humans; Lipids; Mineralocorticoid Receptor Antagonists; Oxidative Stress; Polycystic Ovary Syndrome; Treatment Outcome; Turkey; Waist-Hip Ratio | 2014 |
Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population.
Topics: Adult; Androstenes; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Estradiol; Ethinyl Estradiol; Europe; Female; Humans; Intention to Treat Analysis; Matched-Pair Analysis; Nandrolone; Norpregnenes; Pregnancy; Pregnancy, Unwanted; Progestins; Risk Assessment; South America; Transdermal Patch; United States; Young Adult | 2014 |
Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure, metabolic profile and neurohumoral axis in hypertensive women at reproductive age.
Topics: Adult; Aldosterone; Androstenes; Antihypertensive Agents; Baroreflex; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Electrolytes; Ethinyl Estradiol; Female; Heart Rate; Homeostasis; Humans; Hypertension; Prospective Studies; Triglycerides; Young Adult | 2014 |
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric disorder: a randomized, double blind placebo-controlled study].
Topics: Androstenes; Contraceptives, Oral; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menorrhagia; Metrorrhagia; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Safety; Severity of Illness Index; Treatment Outcome | 2014 |
Comparison of the effects of chlormadinone acetate versus drospirenone containing oral contraceptives on metabolic and hormonal parameters in women with PCOS for a period of two-year follow-up.
Topics: Adult; Androstenes; Blood Glucose; Blood Pressure; C-Reactive Protein; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Insulin Resistance; Longitudinal Studies; Luteinizing Hormone; Polycystic Ovary Syndrome; Treatment Outcome; Triglycerides; Waist-Hip Ratio; Young Adult | 2015 |
Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.
Topics: Adolescent; Adult; Alkaline Phosphatase; Androstenes; Aspartate Aminotransferases; Cholesterol, HDL; Cholesterol, LDL; Collagen Type I; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estetrol; Estrogens; Ethinyl Estradiol; Female; gamma-Glutamyltransferase; Growth Hormone; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Levonorgestrel; Lipid Metabolism; Liver; Mineralocorticoid Receptor Antagonists; Osteocalcin; Peptides; Sex Hormone-Binding Globulin; Triglycerides; Young Adult | 2015 |
Pharmacokinetic interaction between the CYP3A4 inhibitor ketoconazole and the hormone drospirenone in combination with ethinylestradiol or estradiol.
Topics: Adult; Androstenes; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Estradiol; Ethinyl Estradiol; Female; Humans; Ketoconazole; Middle Aged | 2015 |
Effectiveness of ethinylestradiol/drospirenone for premenstrual symptoms in Japanese patients with dysmenorrhea: Open-label pilot study.
Topics: Adult; Androstenes; Drug Therapy, Combination; Dysmenorrhea; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Middle Aged; Mineralocorticoid Receptor Antagonists; Pilot Projects; Premenstrual Syndrome; Prospective Studies; Young Adult | 2015 |
Continuous Norethisterone Acetate versus Cyclical Drospirenone 3 mg/Ethinyl Estradiol 20 μg for the Management of Primary Dysmenorrhea in Young Adult Women.
Topics: Adolescent; Analgesics; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dysmenorrhea; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Jordan; Mineralocorticoid Receptor Antagonists; Norethindrone; Norethindrone Acetate; Pain Measurement; Prospective Studies; Treatment Outcome; Young Adult | 2016 |
Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Endometrium; Estetrol; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Ovarian Follicle; Ovulation; Ovulation Inhibition; Pilot Projects; Pituitary Gland; Progesterone; Ultrasonography; Young Adult | 2015 |
Comparison of two contraceptive pills containing drospirenone and 20 μg or 30 μg ethinyl estradiol for polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Androstenes; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; India; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Young Adult | 2016 |
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adult; Androstenes; Cardiovascular Diseases; Carotid Intima-Media Thickness; Contraceptives, Oral; Ethinyl Estradiol; Exercise; Female; Humans; Hyperandrogenism; Metabolic Diseases; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2016 |
Effect of oral contraceptives on balance in women: A randomized controlled trial.
Topics: Adult; Androstenes; Athletes; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Postural Balance; Progesterone; Progestins; Prospective Studies; Young Adult | 2017 |
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.
Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult | 2018 |
Observation of clinical efficacy of yousiyue for endometrium regeneration after superconducting visual abortion and its nursing.
Topics: Abortion, Induced; Adult; Androstenes; Drug Therapy, Combination; Endometrium; Ethinyl Estradiol; Female; Humans; Menstruation; Regeneration; Treatment Outcome; Ultrasonography; Young Adult | 2018 |
Confirmation of the drug-drug interaction potential between cobicistat-boosted antiretroviral regimens and hormonal contraceptives.
Topics: Adolescent; Adult; Androstenes; Anti-HIV Agents; Area Under Curve; Atazanavir Sulfate; Cobicistat; Cohort Studies; Contraceptives, Oral, Hormonal; Darunavir; Drug Interactions; Ethinyl Estradiol; Female; Half-Life; Humans; Mineralocorticoid Receptor Antagonists; Young Adult | 2019 |
Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Hemostasis; Humans; Menstrual Cycle; Middle Aged; Sex Hormone-Binding Globulin; Young Adult | 2020 |
Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
Topics: Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Sex Hormone-Binding Globulin | 2021 |
Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function.
Topics: Androstenes; Contraceptives, Oral, Combined; Estetrol; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans | 2021 |
Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results.
Topics: Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Humans; North America; Pregnancy | 2021 |
Health Status Is Affected, and Phase I/II Biotransformation Activity Altered in Young Women Using Oral Contraceptives Containing Drospirenone/Ethinyl Estradiol.
Topics: Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Health Status; Humans | 2021 |
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials.
Topics: Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Ethinyl Estradiol; Female; Humans; Pregnancy; Venous Thromboembolism | 2022 |
Drospirenone 4 mg in a 24 + 4 regimen in women with contraindications to oestrogen use for contraception: bleeding patterns according to previous menstrual characteristics.
Topics: Contraception; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraindications; Estrogens; Ethinyl Estradiol; Female; Humans; Male; Menstrual Cycle; Pilot Projects; Prospective Studies; Quality of Life | 2023 |
95 other study(ies) available for ethinyl estradiol and drospirenone
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
Topics: Androgen Antagonists; Androstenes; Animals; Endometrium; Ethinyl Estradiol; Female; Male; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; Orchiectomy; Ovariectomy; Ovulation; Pregnancy; Pregnancy Maintenance; Progesterone; Rabbits; Rats; Sex Differentiation | 1995 |
An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen.
Topics: Adolescent; Adult; Androstenes; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Lipids; Menstruation Disturbances; Mineralocorticoid Receptor Antagonists; Patient Compliance; Progesterone Congeners; Surveys and Questionnaires; Uterine Hemorrhage | 2000 |
Fluid retention with oral contraceptives.
Topics: Androstenes; Body Fluids; Contraceptives, Oral; Estradiol Congeners; Ethinyl Estradiol; Humans; Mineralocorticoid Receptor Antagonists; Renin-Angiotensin System | 2000 |
Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium.
Topics: Adult; Androstenes; Atrophy; Cell Division; Contraceptives, Oral; Drug Combinations; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Progesterone Congeners; Ultrasonography | 2001 |
Oral contraception update: focus on a new progestin. November 2002.
Topics: Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Progestins | 2002 |
Safety and efficacy of a new oral contraceptive containing drospirenone.
Topics: Androstenes; Body Weight; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pregnancy; Progesterone Congeners; Randomized Controlled Trials as Topic | 2002 |
Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Middle Aged; Patient Satisfaction; Premenstrual Syndrome; Probability; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2003 |
Use of an oral contraceptive containing drospirenone in an extended regimen.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dose-Response Relationship, Drug; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Germany; Humans; Menstruation Disturbances; Patient Satisfaction; Progesterone Congeners; Quality of Life; Surveys and Questionnaires; Time Factors; Women's Health | 2003 |
Conception and pharmacodynamic profile of drospirenone.
Topics: Androgen Antagonists; Androstenes; Animals; Blood Pressure; Central Nervous System; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization; Humans; Kidney; Male; Mineralocorticoid Receptor Antagonists; Models, Chemical; Models, Molecular; NG-Nitroarginine Methyl Ester; Pregnancy; Protein Binding; Rats; Rats, Wistar; Renin-Angiotensin System; Sex Factors; Time Factors | 2003 |
Transient ischaemic attack associated with the new contraceptive Yasmin.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Ischemic Attack, Transient; Thromboembolism | 2003 |
Ethinyl estradiol/drospirenone (Yasmin): a newer oral contraceptive.
Topics: Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Progesterone Congeners | 2004 |
Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Androstenes; Biomarkers; Body Mass Index; Bone Density; Bone Remodeling; Contraceptives, Oral; Creatinine; Ethinyl Estradiol; Female; Humans; Osteocalcin; Progesterone; Sex Hormone-Binding Globulin; Testosterone; Waist-Hip Ratio | 2004 |
Drospirenone and PCOS.
Topics: Androstenes; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pilot Projects; Polycystic Ovary Syndrome | 2005 |
Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
Topics: Androstenes; Animals; Antithrombins; Blood Coagulation; Cholesterol; Estrogens; Ethinyl Estradiol; Female; Humans; Lipoproteins; Models, Animal; Norethindrone; Norethindrone Acetate; Norethynodrel; Ovariectomy; Progestins; Promegestone; Rats; Rats, Sprague-Dawley | 2005 |
Prospective study on sexual behavior of women using 30 microg ethinylestradiol and 3 mg drospirenone oral contraceptive.
Topics: Adult; Androstenes; Body Mass Index; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Orgasm; Patient Satisfaction; Prospective Studies; Sexual Behavior; Surveys and Questionnaires; Time Factors | 2005 |
[Myocardial infarction in a young female smoker taking oral contraception].
Topics: Adult; Androstenes; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Myocardial Infarction; Pregnancy; Pregnancy, Ectopic; Smoking | 2006 |
Determining the time androgens and sex hormone-binding globulin take to return to baseline after discontinuation of oral contraceptives in women with polycystic ovary syndrome: a prospective study.
Topics: Adult; Androgens; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Substance Withdrawal Syndrome; Time Factors | 2007 |
Serum potassium monitoring for users of ethinyl estradiol/drospirenone taking medications predisposing to hyperkalemia: physician compliance and survey of knowledge and attitudes.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Child; Contraceptives, Oral, Combined; Drug Monitoring; Drug Utilization; Ethinyl Estradiol; Female; Guideline Adherence; Humans; Hyperkalemia; Insurance Claim Review; Middle Aged; Potassium; Practice Patterns, Physicians'; Progesterone Congeners; United States | 2007 |
Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Evaluation; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Prospective Studies | 2007 |
Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
Topics: Adolescent; Adult; Androstenes; Child; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Middle Aged; Proportional Hazards Models; Risk Assessment; Risk Factors; Thromboembolism | 2007 |
Erythema multiforme limited to the oral mucosa in a teenager on oral contraceptive therapy.
Topics: Adolescent; Androstenes; Contraceptives, Oral, Combined; Diagnosis, Differential; Drug Eruptions; Erythema Multiforme; Estrogens; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Mouth Diseases; Mouth Mucosa | 2007 |
The concomitant prescribing of ethinyl estradiol/drospirenone and potentially interacting drugs.
Topics: Adult; Androstenes; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Contraceptives, Oral, Hormonal; Databases, Factual; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Hyperkalemia; Medical Audit; Mineralocorticoid Receptor Antagonists; Practice Patterns, Physicians'; Retrospective Studies; Sodium Channel Blockers | 2007 |
The new extended regimen for the management of premenstrual symptoms needs to be properly assessed.
Topics: Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome | 2007 |
Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
Topics: Acne Vulgaris; Adult; Androgen Receptor Antagonists; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Prospective Studies; Spironolactone; Treatment Outcome | 2008 |
Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy.
Topics: Adult; Aldosterone; Androstenes; Contraceptives, Oral, Hormonal; Contraindications; Ethinyl Estradiol; False Positive Reactions; Female; Humans; Hyperaldosteronism; Renin | 2007 |
Evaluation of the quality of life and sexual functioning of women using a 30-microg ethinyloestradiol and 3-mg drospirenone combined oral contraceptive.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Health Status; Humans; Middle Aged; Quality of Life; Sexual Dysfunction, Physiological | 2008 |
Pituitary-ovarian hormone levels and symptoms in oral contraceptive users: comparison of a 21/7-day and extended regimen.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral; Drug Administration Schedule; Estradiol; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Inhibins; Luteinizing Hormone; Middle Aged; Mineralocorticoid Receptor Antagonists; Prospective Studies | 2008 |
Confluent and reticulated papillomatosis associated with polycystic ovary syndrome treated with a combined contraceptive containing drospirenone.
Topics: Adult; Androstenes; Ethinyl Estradiol; Female; Humans; Papilloma; Polycystic Ovary Syndrome | 2009 |
[Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg].
Topics: Adolescent; Adult; Androstenes; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Norpregnenes; Severity of Illness Index; Skin; Treatment Outcome | 2008 |
Corneal copper deposition secondary to oral contraceptives.
Topics: Adult; Androstenes; Ceruloplasmin; Contraceptives, Oral; Copper; Corneal Diseases; Descemet Membrane; Estrogens; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Pigmentation Disorders | 2008 |
Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives.
Topics: Adult; Androstenes; Cohort Studies; Contraception; Contraceptives, Oral; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hyperkalemia; Logistic Models; Mineralocorticoid Receptor Antagonists; Outcome Assessment, Health Care; Risk; United States; United States Food and Drug Administration | 2008 |
An oral contraceptive with 3 approved indications.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome | 2008 |
YAZ and the novel progestin drospirenone.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Molecular Structure; Patient Satisfaction; Premenstrual Syndrome | 2008 |
YAZ in the treatment of premenstrual dysphoric disorder.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Approval; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors | 2008 |
Advances in the treatment of acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Anti-Infective Agents, Local; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Tretinoin | 2008 |
Bayer to spend $20m to correct misleading advertising for oral contraceptive Yaz.
Topics: Advertising; Androstenes; Contraceptives, Oral, Combined; Drug Industry; Ethinyl Estradiol; Female; Humans; United States | 2009 |
User satisfaction with the combined oral contraceptive drospirenone 3 mg/ethinylestradiol 20 microg (Yasminelle) in clinical practice: a multi-country, questionnaire-based study.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Drug Combinations; Drug Eruptions; Ethinyl Estradiol; Female; Humans; Ireland; Menstruation; Patient Satisfaction; Premenstrual Syndrome; Surveys and Questionnaires; Weight Gain; Young Adult | 2009 |
Effects of oral contraception with ethinylestradiol and drospirenone on oxidative stress in women 18-35 years old.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral, Combined; Copper; Down-Regulation; Ethinyl Estradiol; Female; HSP70 Heat-Shock Proteins; Humans; Lipid Peroxides; Nitric Oxide Synthase; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Reactive Oxygen Species; Up-Regulation; Young Adult | 2009 |
International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study).
Topics: Adolescent; Adult; Androstenes; Cardiovascular Diseases; Cohort Studies; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Internationality; Population Surveillance; Progestins; Research Design; Young Adult | 2009 |
The effect of a continuous regimen of drospirenone 3 mg/ethinylestradiol 30 microg on Cox-2 and Ki-67 expression in the endometrium.
Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endometrium; Estrogens; Ethinyl Estradiol; Female; Humans; Ki-67 Antigen; Mineralocorticoid Receptor Antagonists; Observation; Uterine Hemorrhage | 2010 |
Presumed corneal copper deposition and oral contraceptive use.
Topics: Androstenes; Contraceptives, Oral; Copper; Corneal Opacity; Descemet Membrane; Ethinyl Estradiol; Female; Functional Laterality; Humans; Pigmentation Disorders; Young Adult | 2010 |
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Topics: Adolescent; Adult; Androstenes; Case-Control Studies; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Logistic Models; Middle Aged; Mineralocorticoid Receptor Antagonists; Nandrolone; Risk Factors; Venous Thromboembolism; Young Adult | 2010 |
A prospective follow-up of two 21/7 cycles followed by two extended regimen 84/7 cycles with contraceptive pills containing ethinyl estradiol and drospirenone.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstruation; Menstruation Disturbances; Mineralocorticoid Receptor Antagonists; Patient Satisfaction; Prospective Studies; Quality of Life; Surveys and Questionnaires | 2010 |
[Short-term effect of an estroprogestin containing ethinylestradiol 20 mcg + drospirenone 3 mg in 24+4 regimen at hormonal and cutaneous level in ovarian hyperandrogenism].
Topics: Administration, Oral; Adolescent; Adult; Androstenes; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Norpregnenes; Severity of Illness Index; Time Factors; Treatment Outcome | 2010 |
SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
Topics: Androstenes; Canada; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Risk Factors; Venous Thromboembolism | 2010 |
Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration.
Topics: Adult; Aldosterone; Androstenes; Blood Pressure; Chromatography, High Pressure Liquid; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Immunoassay; Luteinizing Hormone; Progesterone; Renin; Reproductive Control Agents; Tandem Mass Spectrometry | 2011 |
Drospirenone: high risk of venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Venous Thrombosis | 2011 |
Oral contraceptives and the risk of gallbladder disease: a comparative safety study.
Topics: Adult; Androstenes; Cholecystectomy; Confidence Intervals; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Gallbladder Diseases; Humans; Levonorgestrel; Progestins; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors | 2011 |
Myocardial infarction and spontaneous dissection of coronary artery due to oral contraceptive.
Topics: Adult; Androstenes; Aortic Dissection; Contraceptives, Oral; Coronary Aneurysm; Coronary Occlusion; Coronary Thrombosis; Ethinyl Estradiol; Female; Humans; Myocardial Infarction | 2011 |
Do drospirenone-containing oral contraceptives have a higher risk of VTE?
Topics: Adult; Androstenes; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Venous Thromboembolism | 2011 |
[Sinus thrombosis in a healthy female taking oral contraceptives].
Topics: Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed; Young Adult | 2011 |
Risk of blood clots higher for oral contraceptives with certain progestins.
Topics: Androstenes; Contraceptives, Oral; Cyproterone; Denmark; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progestins; Registries; Risk; Venous Thromboembolism | 2011 |
A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinylestradiol 3 mg/20 mcg.
Topics: Adult; Androstenes; Combined Modality Therapy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometriosis; Ethinyl Estradiol; Female; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Ovarian Diseases; Pilot Projects; Postoperative Period; Retrospective Studies; Treatment Outcome | 2012 |
The association between drospirenone and hyperkalemia: a comparative-safety study.
Topics: Adult; Androstenes; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Hyperkalemia; Levonorgestrel; Logistic Models; Proportional Hazards Models; Retrospective Studies; Risk Factors; Spironolactone | 2011 |
Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome.
Topics: Androstenes; Ethinyl Estradiol; Female; Humans; Male; Metformin; Middle Aged; Polycystic Ovary Syndrome; Thinness | 2013 |
Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women.
Topics: Adult; Androstenes; Asian People; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Reproductive Control Agents; White People | 2012 |
Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio.
Topics: Adult; Aldosterone; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progestins; Renin; Renin-Angiotensin System; Young Adult | 2012 |
Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination.
Topics: Adolescent; Adult; Androstenes; Body Composition; Case-Control Studies; Contraceptives, Oral, Combined; Estrogens; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Thinness; Young Adult | 2013 |
Combination of injectable ethinyl estradiol and drospirenone drug-delivery systems and characterization of their in vitro release.
Topics: Androstenes; Capsules; Cyanoacrylates; Drug Delivery Systems; Enbucrilate; Ethinyl Estradiol; Injections; Kinetics; Lactic Acid; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Suspensions | 2012 |
[Jangee – young, free and beautiful].
Topics: Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists | 2012 |
Another flawed database study.
Topics: Androstenes; Contraceptive Agents, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Norgestrel; Venous Thromboembolism | 2013 |
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study.
Topics: Adolescent; Adult; Androstenes; Blood Pressure; Cardiovascular Diseases; Circadian Rhythm; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Heart Rate; Humans; Hypertension; Young Adult | 2013 |
Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?
Topics: Adolescent; Adult; Androstenes; Cohort Studies; Contraceptives, Oral; Databases, Factual; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Proportional Hazards Models; Risk; Time Factors; United States; Venous Thromboembolism; Young Adult | 2013 |
Low-dose estrogen and drospirenone combination: effects on metabolism and endothelial function in postmenopausal women with metabolic syndrome.
Topics: Androstenes; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Cholesterol; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Humans; Metabolic Syndrome; Middle Aged; Postmenopause; Risk Factors; Triglycerides; Vasodilation | 2013 |
Basal and meal-stimulated ghrelin, PYY, CCK levels and satiety in lean women with polycystic ovary syndrome: effect of low-dose oral contraceptive.
Topics: Adolescent; Adult; Androstenes; Basal Metabolism; Body Weight; Cholecystokinin; Contraceptives, Oral; Eating; Estrogens; Ethinyl Estradiol; Female; Ghrelin; Humans; Mineralocorticoid Receptor Antagonists; Peptide YY; Polycystic Ovary Syndrome; Prospective Studies; Satiety Response; Young Adult | 2013 |
Hyperandrogenic women treated with a continuous-regimen oral contraceptive.
Topics: Acne Vulgaris; Adolescent; Androgens; Androstenes; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 2013 |
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women.
Topics: Adult; Androstenes; Blood Glucose; Cholesterol, HDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Triglycerides | 2014 |
Effect of a low dose combined oral contraceptive pill on the hormonal profile and cycle outcome following COS with a GnRH antagonist protocol in women over 35 years old.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Menstrual Cycle; Ovulation Induction; Pregnancy; Pregnancy Rate; Treatment Outcome | 2014 |
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in a 24+4-day regimen in China].
Topics: Adolescent; Adult; Androstenes; Body Weight; China; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation; Mineralocorticoid Receptor Antagonists; Pregnancy; Pregnancy Rate; Treatment Outcome; Uterine Hemorrhage; Young Adult | 2014 |
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.
Topics: Adiponectin; Adipose Tissue; Adult; Androstenes; Anthropometry; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Egypt; Ethinyl Estradiol; Female; Humans; Leptin; Levonorgestrel; Norpregnenes; Resistin; Risk Factors | 2015 |
Effects of low dose oral contraceptive pill containing drospirenone/ethinylestradiol in patients with endometrioma.
Topics: Adult; Androstenes; Biomarkers; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Middle Aged; Organ Size; Ovarian Diseases; Ovarian Reserve; Ovary; Pain Measurement; Progesterone Congeners; Ultrasonography; Young Adult | 2015 |
Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.
Topics: Adult; Aldosterone; Androstenedione; Androstenes; Blood Pressure; Body Mass Index; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Healthy Volunteers; Humans; Insulin Resistance; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System; Testosterone; Triglycerides | 2015 |
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
Topics: Adult; Androstenes; Cardiovascular Diseases; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Mineralocorticoid Receptor Antagonists; Patient Reported Outcome Measures; Pharmacovigilance; Progestins; Proportional Hazards Models; Risk Factors | 2016 |
Activity of binary mixtures of drospirenone with progesterone and 17α-ethinylestradiol in vitro and in vivo.
Topics: Androstenes; Animals; Estrogen Receptor alpha; Ethinyl Estradiol; Fish Proteins; Gene Expression Regulation, Developmental; Humans; Progesterone; Receptors, Androgen; Receptors, Progesterone; Saccharomyces cerevisiae; Water Pollutants, Chemical; Zebrafish | 2016 |
Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Androgen Antagonists; Androstenes; Anti-Bacterial Agents; Benzoyl Peroxide; Canada; Clindamycin; Cyproterone Acetate; Dermatologic Agents; Doxycycline; Drug Combinations; Estrogens; Ethinyl Estradiol; Humans; Isotretinoin; Mineralocorticoid Receptor Antagonists; Minocycline; Practice Guidelines as Topic; Severity of Illness Index; Tetracycline | 2016 |
Autoimmune progesterone dermatitis: Case report of an unexpected treatment reaction.
Topics: Administration, Intravaginal; Adult; Androstenes; Autoimmune Diseases; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Dermatitis; Desogestrel; Ethinyl Estradiol; Female; Humans; Luteal Phase; Progesterone; Urticaria | 2017 |
Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol.
Topics: Adolescent; Adult; Androstenes; Angiotensinogen; Anticoagulants; Biomarkers; Blood Coagulation; Contraceptives, Oral; Estetrol; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Hemostasis; Humans; Sex Hormone-Binding Globulin; Young Adult | 2017 |
[Comparison among measures to prevent intrauterine adhesions after artificial abortion].
Topics: Abortion, Induced; Androstenes; Endometrium; Ethinyl Estradiol; Female; Humans; Hyaluronic Acid; Menstrual Cycle; Menstruation; Pregnancy; Tissue Adhesions | 2016 |
Drospirenone reduces inflammatory cytokines, vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) expression in human endometriotic stromal cells.
Topics: Adult; Androstenes; Anti-Inflammatory Agents; Cells, Cultured; Contraceptives, Oral; Cytokines; Endometriosis; Endometrium; Ethinyl Estradiol; Female; Humans; Nerve Growth Factor; Receptors, Mineralocorticoid; Receptors, Progesterone; RNA, Small Interfering; Stromal Cells; Vascular Endothelial Growth Factor A | 2017 |
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult | 2017 |
Very low dose of flutamide in the treatment of hyperandrogenism.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Androstenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Norpregnenes; Treatment Outcome; Young Adult | 2018 |
The Effect of Oral Contraceptive Pills on the Macula, the Retinal Nerve Fiber Layer, and Choroidal Thickness.
Topics: Adult; Androstenes; Choroid; Contraceptives, Oral; Ethinyl Estradiol; Eye Diseases; Female; Humans; Macula Lutea; Nerve Fibers; Retina; Retinal Ganglion Cells; Retinal Neurons; Tomography, Optical Coherence | 2017 |
Autoimmune Progesterone Dermatitis: A Case Report.
Topics: Adult; Androstenes; Autoimmune Diseases; Contraceptives, Oral, Combined; Dermatitis; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Progesterone; Recurrence; Skin Tests; Treatment Outcome | 2019 |
Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone.
Topics: Androstenes; Animals; Blood Glucose; Body Weight; Contraceptives, Oral; Corticosterone; Drug Combinations; Ethinyl Estradiol; Female; Insulin; Insulin-Secreting Cells; Levonorgestrel; Rats | 2019 |
The Effect of Oral Contraceptive Hormones on Anterior Cruciate Ligament Strength.
Topics: Androstenes; Animals; Anterior Cruciate Ligament; Biomechanical Phenomena; Contraceptives, Oral; Estrogens; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Norethindrone; Norgestrel; Progestins; Rats; Rats, Sprague-Dawley | 2020 |
Mechanical and Physical Behavior of Fibrin Clot Formation and Lysis in Combined Oral Contraceptive Users.
Topics: Adolescent; Adult; Androstenes; Blood Coagulation; Blood Coagulation Tests; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Fibrin; Humans; Male; Microscopy, Electron, Scanning; Thrombelastography; Thrombosis; Venous Thromboembolism; Viscosity; Young Adult | 2020 |
Genotoxic effects of drospirenone and ethinylestradiol in human breast cells (
Topics: Androstenes; Animals; Bone Marrow Cells; Comet Assay; Contraceptives, Oral; DNA Damage; Ethinyl Estradiol; Female; Humans; Mice | 2022 |
The effect of combined oral contraceptives containing drospirenone and ethinylestradiol on serum levels of amino acids and acylcarnitines.
Topics: Amino Acids; Androstenes; Carnitine; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans | 2021 |
Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone.
Topics: Contraceptives, Oral, Combined; Estetrol; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Thrombin | 2022 |
The progestin-only pills drospirenone 4 mg and desogestrel 0.075 mg as an option for the management of dysmenorrhea and mastodynia.
Topics: Contraceptives, Oral, Combined; Desogestrel; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Mastodynia; Pregnancy; Progesterone Congeners; Progestins | 2022 |
Ultrasound-Assisted Extraction, Followed by Gas Chromatography-Mass Spectrometry for the Simultaneous Quantification of Ethinyl Estradiol and Drospirenone in Contraceptive Formulations.
Topics: Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Gas Chromatography-Mass Spectrometry; Humans; Tablets | 2023 |
RP-HPLC method to assay ethinylestradiol and drospirenone with 3D chromatograph model in fixed dose in rat plasma for pharmacokinetic study analysis.
Topics: Administration, Oral; Animals; Biological Assay; Chromatography, High Pressure Liquid; Ethinyl Estradiol; Rats | 2023 |
A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns.
Topics: Androstenes; Antithrombin III; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Progestins; Prospective Studies | 2023 |